Showing results (601-610 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|December 17, 2004
Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson diseaseMalgorzata Chalimoniuk, A Stepień, J B StrosznajderClinical Neuropharmacology|December 17, 2004
Evidence-based review of patient-reported outcomes with botulinum toxin type AJoseph Jankovic, Alberto Esquenazi, Darcy Fehlings, et al.Clinical Neuropharmacology|December 23, 2004
Dementia with lewy bodies: implications for clinical trialsBarbara Collins, John Constant, Samer Kaba, et al.Clinical Neuropharmacology|December 23, 2004
Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptylinePhilippos Gourzis, Panagiotis Polychronopoulos, Andreas A Argyriou, et al.Clinical Neuropharmacology|February 16, 2005
Hypothesized deficiency of guanine-based purines may contribute to abnormalities of neurodevelopment, neuromodulation, and neurotransmission in Lesch-Nyhan syndromeStephen I Deutsch, Katrice D Long, Richard B Rosse, et al.Clinical Neuropharmacology|August 21, 2004
Plasma homocysteine levels in pergolide-treated Parkinson disease patientsSerhat Ozkan, Omer Colak, Ceyhan Kutlu, et al.Clinical Neuropharmacology|August 21, 2004
Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer diseaseRoberto Ceravolo, Duccio Volterrani, Gloria Tognoni, et al.Clinical Neuropharmacology|August 21, 2004
Combined quinacrine and chlorpromazine therapy in fatal familial insomniaJulián Benito-LeónClinical Neuropharmacology|June 11, 2004
Frequency, reasons, and risk factors of entacapone discontinuation in Parkinson diseaseSotirios A Parashos, Catherine L Wielinski, Jessica A KernClinical Neuropharmacology|June 11, 2004
Citalopram as treatment of depression in patients with epilepsyLuigi M Specchio, Alfonso Iudice, Nicola Specchio, et al.Pageof 236